What is Clinical Microbiology Market?
Clinical Microbiology is becoming a crucial requirement from many industries including healthcare, food, consumer products, cosmetics and beauty products, medical devices, fuels, drinking water, and oil exploration, across the globe. It is concerned with the prevention, diagnosis, and treatment of infectious diseases. The constant changes in viruses such as influenza, HIV, tuberculosis, malaria, and SARS are a massive challenge to modern medicine and public health. The microbiology testing industry is going under several technological advancements that will help to reshape this field. The tools and instruments present in the microbiology laboratories are constantly developing intending to decrease the overall time taken to obtain the results, enhance ease of sample processing, and increase sample turnaround time. This field is moving exceptionally fast, in part because it can take full advantage of the new developments. According to the study, the global microbiology testing market reached around USD ~14,819.44 Million, FY2019. From which the major ratio is covered by North America, and followed by Europe and the Asia Pacific. Here the Asia Pacific accounts ~19% from the global market. In the Asia Pacific region, China and Japan are covering major market share. Here, China covered around ~27% of the total Asia Pacific market. The major trend in the China region is the rapid adoption of microbiology testing for blood cultures. Becton Dickinson and BioMerieux are dominant players in the Chinese market. In China, microbiology testing is also high adopted for TB diagnosis, because in China they are frequently looking drug-resistant for TB diagnosis.
The market study is being classified, by Application (Pharmaceutical, Food Testing, Energy, Chemical and Material Manufacturing and Environment) and major geographies with country level break-up.
3M (United States), Agilent Technologies Inc. (United States), Avantor (United States), Becton Dickinson (United States), Biomrieux SA (France), Bio-Rad Laboratories (United States), Danaher Corporation (United States), NEOGEN Corporation (United States), Merck (United States) and Thermo Fisher Scientific (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Hologic (United States), Bruker (United States) and Roche Diagnostics (Switzerland).
The market is seeing an increasing number of market players, by witnessing rapid growth in this market the market-leading players are strongly focusing on the production technologies, efficiency enhancement, and others. There is a various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and highly investing in research and development. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Clinical Microbiology market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Clinical Microbiology market by Type, Application and Region.
On the basis of geography, the market of Clinical Microbiology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Occurrence of Infectious Diseases
- Growing Outbreaks of Epidemics
- Collaboration and Tie Up of Leading Players
- Stringent Government Regulations
- The Explosion of Real-Time PCR is creating the Microbiology Testing Market
- Limited Reimbursement Policies Hampers the Microbiology Testing Market
In 2019, bioMérieux announced the acquisition of Invisible Sentinel, a company engaged in the development of molecular diagnostic tools for the rapid, accurate, and reliable detection of pathogens. Through this initiative, the company aims to capture major market share in the market.
Key Target AudienceVenture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Clinical Microbiology, Government Regulatory and Research Organizations and End-Use Industries
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase